scispace - formally typeset
Open AccessJournal ArticleDOI

Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy

TLDR
Even low-level viremia among HIV controllers was associated with measurable T cell dysfunction, which has implications for current prophylactic vaccine strategies.
Abstract
Background Spontaneous control of human immunodeficiency virus (HIV) infection has been documented in a minority of HIV-infected individuals. The mechanisms behind this outcome remain largely unknown, and a better understanding of them will likely influence future vaccine strategies. Methods HIV-specific T cell and antibody responses as well as host genetics were examined in untreated HIV-infected patients who maintain comparatively low plasma HIV RNA levels (hereafter, controllers), including those with levels of 10,000 copies/mL (chronic progressors, n = 30). Results CD8+ T cells from both controller groups preferentially target Gag over other proteins in the context of diverse HLA class I alleles, whereas responses are more broadly distributed in persons with progressive infection. Elite controllers represent a distinct group of individuals who have significantly more CD4 and CD8 T cells that secrete interferon-gamma and interleukin-2 and lower levels of HIV-neutralizing antibodies. Individual responses were quite heterogeneous, and none of the parameters evaluated was uniquely associated with the ability to control viremia. Conclusions Elite controllers are a distinct group, even when compared to persons with low level viremia, but they exhibit marked genetic and immunologic heterogeneity. Even low-level viremia among HIV controllers was associated with measurable T cell dysfunction, which has implications for current prophylactic vaccine strategies.

read more

Citations
More filters
Journal ArticleDOI

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

Florencia Pereyra, +336 more
- 10 Dec 2010 - 
TL;DR: Differences in binding to viral peptide antigens by HLA may be the major factors underlying genetic differences between HIV controllers and progressors, and genome-wide association results implicate the nature of the HLA–viral peptide interaction as the major factor modulating durable control of HIV infection.
Journal ArticleDOI

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

TL;DR: Chronic inflammation – which is higher in controllers than in HIV-uninfected persons – may account for early atherosclerosis in these patients, which can occur in the absence of antiretroviral therapy, detectable viremia, or overt immunodeficiency.
References
More filters
Journal ArticleDOI

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

TL;DR: The β-chemokine receptor CC-CKR-5 as mentioned in this paper is a second receptor for NSI primary viruses, which allows env-mediated cell-cell membrane fusion, but it does not allow the fusion of cells from some HIV-1-exposed uninfected individuals.
Journal ArticleDOI

Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1

TL;DR: The viral load is the chief predictor of the risk of heterosexual transmission of HIV-1, and transmission is rare among persons with levels of less than 1500 copies of HIV -1 RNA per milliliter.
Journal ArticleDOI

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

TL;DR: In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1-specific CD4+ T cell proliferative responses were present, resulting in the elaboration of interferon-gamma and antiviral beta chemokines.
Journal ArticleDOI

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

TL;DR: The quality of the HIV-specific CD8(+) T-cell functional response serves as an immune correlate of HIV disease progression and a potential qualifying factor for evaluation of HIV vaccine efficacy.
Journal ArticleDOI

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

TL;DR: The extended survival of 28 to 40 percent of HIV-1-infected Caucasian patients who avoided AIDS for ten or more years can be attributed to their being fully heterozygous at HLA class I loci, to their lacking the AIDS-associated alleles B*35 and Cw*04, or to both.
Related Papers (5)

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

Florencia Pereyra, +336 more
- 10 Dec 2010 -